Cite
HARVARD Citation
Van de Vondel, S. et al. (2018). Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study. Inflammatory bowel diseases. 24 (5), pp. 1099-1105. [Online].